Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2862008rdf:typepubmed:Citationlld:pubmed
pubmed-article:2862008lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:2862008lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2862008lifeskim:mentionsumls-concept:C0032008lld:lifeskim
pubmed-article:2862008lifeskim:mentionsumls-concept:C0733758lld:lifeskim
pubmed-article:2862008lifeskim:mentionsumls-concept:C0023607lld:lifeskim
pubmed-article:2862008lifeskim:mentionsumls-concept:C0597879lld:lifeskim
pubmed-article:2862008lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:2862008pubmed:issue2lld:pubmed
pubmed-article:2862008pubmed:dateCreated1985-8-29lld:pubmed
pubmed-article:2862008pubmed:abstractTextRat anterior pituitary quarters or acutely dispersed rat anterior pituitary cells were incubated in vitro, and the release of dynorphin A1-13-like immunoreactivity (Dyn A1-13-IR) into the incubation medium was studied. Addition of LHRH led to a concentration-dependent enhancement of the release of Dyn A1-13-IR with a maximum secretory rate which was about 4-fold higher than basal secretion. Dyn A1-13-IR was released by LHRH concomitantly with LH and FSH, and the concentration-response relationships as well as the time course were virtually identical. Gel filtration and HPLC revealed a single peak of Dyn A1-13-IR, with an apparent mol wt of about 6000. In addition to Dyn A1-13-IR, alpha-neo-endorphin-like immunoreactivity was released by LHRH. The LHRH-stimulated release of Dyn A1-13-IR was mimicked by the LHRH analog D-Ala6,des-Gly10-LHRH ethylamide and blocked in a competitive manner by the LHRH antagonist D-pGlu1,D-Phe2,D-Trp3,6-LHRH. Addition of TRH (5 microM), rat corticotropin-releasing factor (100 nM), arginine vasopressin (1 microM), or synthetic human pancreatic GH-releasing hormone (10 nM) produced no effect on Dyn A1-13-IR release. An extract of the rat medial basal hypothalamus stimulated the release of Dyn A1-13-IR and beta-endorphin-like immunoreactivity, and the former, but not the latter, effect was blocked by the LHRH antagonist D-pGlu1,D-Phe2,D-Trp3,6-LHRH. These results demonstrate that dynorphin-like material and other proenkephalin B-derived peptides are released concomitantly with LH and FSH from rat adenohypophysis in vitro upon activation of LHRH receptors. This may indicate that proenkephalin B-derived peptides coexist with LH and/or FSH in at least some gonadotrophs of the normal rat anterior pituitary gland.lld:pubmed
pubmed-article:2862008pubmed:languageenglld:pubmed
pubmed-article:2862008pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2862008pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2862008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2862008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2862008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2862008pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2862008pubmed:statusMEDLINElld:pubmed
pubmed-article:2862008pubmed:monthAuglld:pubmed
pubmed-article:2862008pubmed:issn0013-7227lld:pubmed
pubmed-article:2862008pubmed:authorpubmed-author:DöhlerK DKDlld:pubmed
pubmed-article:2862008pubmed:authorpubmed-author:KnepelWWlld:pubmed
pubmed-article:2862008pubmed:authorpubmed-author:SchwaningerMMlld:pubmed
pubmed-article:2862008pubmed:issnTypePrintlld:pubmed
pubmed-article:2862008pubmed:volume117lld:pubmed
pubmed-article:2862008pubmed:ownerNLMlld:pubmed
pubmed-article:2862008pubmed:authorsCompleteYlld:pubmed
pubmed-article:2862008pubmed:pagination481-7lld:pubmed
pubmed-article:2862008pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:meshHeadingpubmed-meshheading:2862008-...lld:pubmed
pubmed-article:2862008pubmed:year1985lld:pubmed
pubmed-article:2862008pubmed:articleTitleCorelease of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro.lld:pubmed
pubmed-article:2862008pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2862008pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2862008pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2862008lld:pubmed